About Us

The DCNN works to advance our understanding of neurodegenerative disease, with the expectation that such advances will offer opportunities for leveraging acquired mechanistic knowledge into substantive opportunities for therapy development.

Andrew West, PhD
Director, Duke Center for Neurodegeneration and Neurotherapeutics
Professor of Pharmacology and Cancer Biology
Read Dr. West’s “Profiles in Brain Sciences” interview here.